Atlas Trials

Surufatinib Renal Impairment Study

Clinical trial NCT04755088 · COMPLETED

Trial details

NCT number
NCT04755088
Sponsor
Hutchison Medipharma Limited
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Renal Impairment
Start date
2021-02-12
Primary completion
2021-08-21
Enrollment
16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.